FORWARD I: a Phase III study of mirvetuximab soravtansine versus chemotherapy in platinum-resistant ovarian cancer

Future Oncology, Ahead of Print.

Source: Future Oncology - February 9, 2018 Category: Cancer & Oncology Authors: Kathleen N Moore Ignace Vergote Ana Oaknin Nicoletta Colombo Susana Banerjee Amit Oza Patricia Pautier Karim Malek Michael J Birrer Source Type: research